Results 111 to 120 of about 3,857 (191)

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. [PDF]

open access: yes, 2019
Purpose:To evaluate the safety, recommended phase II dose (RP2D) and efficacy of pexidartinib, a colony stimulating factor receptor 1 (CSF-1R) inhibitor, in combination with weekly paclitaxel in patients with advanced solid tumors.
Coussens, Lisa M   +12 more
core  

Orthopaedics [PDF]

open access: yes, 2005
下条 竜一   +10 more
core   +3 more sources

Synovial Sarcoma Disguised as a Ganglion Cyst in a Patient with Chronic Knee Pain. [PDF]

open access: yesJ Orthop Case Rep
Selvaraj A   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy